JP2022532877A5 - - Google Patents
Info
- Publication number
- JP2022532877A5 JP2022532877A5 JP2021566284A JP2021566284A JP2022532877A5 JP 2022532877 A5 JP2022532877 A5 JP 2022532877A5 JP 2021566284 A JP2021566284 A JP 2021566284A JP 2021566284 A JP2021566284 A JP 2021566284A JP 2022532877 A5 JP2022532877 A5 JP 2022532877A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- solvate
- acceptable salt
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962845119P | 2019-05-08 | 2019-05-08 | |
| US62/845,119 | 2019-05-08 | ||
| US201962884588P | 2019-08-08 | 2019-08-08 | |
| US62/884,588 | 2019-08-08 | ||
| PCT/US2020/031925 WO2020227563A1 (en) | 2019-05-08 | 2020-05-07 | Jak inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022532877A JP2022532877A (ja) | 2022-07-20 |
| JP2022532877A5 true JP2022532877A5 (enExample) | 2023-05-16 |
| JP7617030B2 JP7617030B2 (ja) | 2025-01-17 |
Family
ID=73051620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021566284A Active JP7617030B2 (ja) | 2019-05-08 | 2020-05-07 | Ｊａｋ阻害剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11136329B2 (enExample) |
| EP (1) | EP3966209A4 (enExample) |
| JP (1) | JP7617030B2 (enExample) |
| KR (1) | KR102916168B1 (enExample) |
| CN (1) | CN114269734B (enExample) |
| BR (1) | BR112021022380A2 (enExample) |
| CA (1) | CA3139277A1 (enExample) |
| IL (1) | IL287876A (enExample) |
| MX (1) | MX2021013602A (enExample) |
| SG (1) | SG11202112362YA (enExample) |
| TW (1) | TWI865525B (enExample) |
| WO (1) | WO2020227563A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3139277A1 (en) | 2019-05-08 | 2020-11-12 | Vimalan Biosciences, Inc. | Jak inhibitors |
| MX2022001702A (es) | 2019-08-08 | 2022-04-20 | Vimalan Biosciences Inc | Inhibidores de jak. |
| CN114644633B (zh) * | 2020-12-18 | 2026-02-03 | 北京诺诚健华医药科技有限公司 | 杂环类jak抑制剂 |
| KR102637915B1 (ko) * | 2021-06-25 | 2024-02-19 | 한국화학연구원 | 유비퀴틴 프로테오좀 경로를 통해 비티케이 분해작용을 가지는 신규한 이작용성 헤테로사이클릭 화합물과 이의 용도 |
| US12084453B2 (en) | 2021-12-10 | 2024-09-10 | Incyte Corporation | Bicyclic amines as CDK12 inhibitors |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA200802685B (en) | 2005-09-30 | 2009-10-28 | Vertex Pharma | Deazapurines useful as inhibitors of janus kinases |
| TWI398252B (zh) | 2006-05-26 | 2013-06-11 | 諾華公司 | 吡咯并嘧啶化合物及其用途 |
| CA2676665A1 (en) | 2007-01-30 | 2008-08-07 | Biogen Idec Ma Inc. | Modulators of mitotic kinases |
| PE20091485A1 (es) | 2008-02-06 | 2009-10-26 | Novartis Ag | DERIVADOS DE PIRROLO-[2,3-d]-PIRIMIDINA COMO INHIBIDORES DE CINASAS |
| CA2775009A1 (en) * | 2009-10-20 | 2011-04-28 | Cellzome Limited | Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors |
| WO2011134831A1 (en) * | 2010-04-30 | 2011-11-03 | Cellzome Limited | Pyrazole compounds as jak inhibitors |
| WO2011156698A2 (en) | 2010-06-11 | 2011-12-15 | Abbott Laboratories | NOVEL PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS |
| WO2012143320A1 (en) * | 2011-04-18 | 2012-10-26 | Cellzome Limited | (7h-pyrrolo[2,3-d]pyrimidin-2-yl)amine compounds as jak3 inhibitors |
| CN103874699A (zh) * | 2011-09-20 | 2014-06-18 | 赛尔佐姆有限公司 | 吡唑并[4,3-c]吡啶衍生物作为激酶抑制剂 |
| EP2867236B1 (en) | 2012-06-29 | 2017-06-14 | Pfizer Inc | Novel 4-(substituted-amino)-7h-pyrrolo[2,3-d]pyrimidines as lrrk2 inhibitors |
| MX2017016325A (es) | 2015-06-22 | 2018-03-02 | Ono Pharmaceutical Co | Compuesto inhibidor de cinasa de tumor de mama (brk). |
| CN108864057B (zh) * | 2017-05-16 | 2020-03-31 | 山东大学 | 含有4-氨基吡唑结构的jak与hdac双靶点抑制剂及其制备方法和应用 |
| CA3139277A1 (en) | 2019-05-08 | 2020-11-12 | Vimalan Biosciences, Inc. | Jak inhibitors |
| MX2022001702A (es) * | 2019-08-08 | 2022-04-20 | Vimalan Biosciences Inc | Inhibidores de jak. |
| US20230024521A1 (en) * | 2019-09-25 | 2023-01-26 | Vimalan Biosciences, Inc. | Jak inhibitors |
-
2020
- 2020-05-07 CA CA3139277A patent/CA3139277A1/en active Pending
- 2020-05-07 BR BR112021022380A patent/BR112021022380A2/pt unknown
- 2020-05-07 US US16/869,433 patent/US11136329B2/en active Active
- 2020-05-07 WO PCT/US2020/031925 patent/WO2020227563A1/en not_active Ceased
- 2020-05-07 MX MX2021013602A patent/MX2021013602A/es unknown
- 2020-05-07 SG SG11202112362YA patent/SG11202112362YA/en unknown
- 2020-05-07 CN CN202080050268.XA patent/CN114269734B/zh active Active
- 2020-05-07 JP JP2021566284A patent/JP7617030B2/ja active Active
- 2020-05-07 EP EP20801611.3A patent/EP3966209A4/en active Pending
- 2020-05-07 KR KR1020217040186A patent/KR102916168B1/ko active Active
- 2020-05-08 TW TW109115406A patent/TWI865525B/zh active
-
2021
- 2021-11-07 IL IL287876A patent/IL287876A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022532877A5 (enExample) | ||
| JP2022519696A5 (enExample) | ||
| JP2022529311A5 (enExample) | ||
| IL291345B2 (en) | Il-17a modulators and uses thereof | |
| JP2024529839A5 (enExample) | ||
| JP2024520481A5 (enExample) | ||
| JP2022541254A5 (enExample) | ||
| JP2019532928A5 (enExample) | ||
| JP2016530210A5 (enExample) | ||
| JP2021523200A5 (enExample) | ||
| JP2013501074A5 (enExample) | ||
| JP6488359B2 (ja) | ベンズイミダゾール誘導体の製造方法 | |
| JP2016530209A5 (enExample) | ||
| JP2013525448A5 (enExample) | ||
| JP2024512931A5 (enExample) | ||
| JP2020500178A5 (enExample) | ||
| JP2010516844A5 (ja) | 硬化性接着剤組成物 | |
| CN106459024A (zh) | 环丙胺化合物及其用途 | |
| JP2022552445A5 (enExample) | ||
| CN103524440A (zh) | 痛风治疗药Lesinurad的制备方法及Lesinurad中间体 | |
| JP2022509206A5 (enExample) | ||
| JP2019529460A5 (enExample) | ||
| JP2018535261A5 (enExample) | ||
| JP6177524B2 (ja) | 成形材料及び成形体 | |
| HRP20160523T1 (hr) | Antikancerozni steroidni laktoni, nezasićeni na položaju 7(8) |